A5023486622- Cardiovascular Issues in Pregnancy
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Vascular Anomalies and Treatments
- Pulmonary Hypertension Research and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Heart rate and cardiovascular health
- Cardiac Valve Diseases and Treatments
- Cardiovascular Effects of Exercise
- Cardiac Arrhythmias and Treatments
- Congenital Heart Disease Studies
Instituto Nacional de Cardiología
2022-2025
Abstract Introduction Acute Coronary Syndromes are a significant source of morbidity and mortality, particularly in Lower-Middle-Income Countries (LMIC). An emphasis must be placed on prevention cardiovascular disease, to reduce morbidity, mortality hospital costs. Purpose To describe identify which factors entail greater in-hospital cost for patients with ACS. Methods We included 766 NSTEMI/UA & 1975 STEMI from December 2020 September 2023; we compared the coronary care unit, floor...
Objective. Acute myocardial infarction-related cardiogenic shock (AMI-CS) is often accompanied by tachycardia, which, in turn, increases oxygen consumption and hinders the use of ventricular assist devices, such as intra-aortic balloon pump. Evidence suggests that ivabradine may reduce heart rate (HR) without affecting other hemodynamic parameters. The aim present study was to determine effect on reducing HR changes parameters cardiac index (CI), patients with AMI-CS tachycardia. Materials...
Abstract Introduction Post-infarction ventricular septal defect (VSD) is a rare but life-threatening complication of acute myocardial infarction (AMI). Surgical closure (SC) has traditionally been the standard treatment, in recent years, percutaneous transcatheter (PC) emerged as an alternative. This study aims to investigate potential for "immortal time bias" treatment selection post-infarction VSD. Methods 8,022 patients who presented with STEMI, whom 80 (1%) had Among these: 26 SC, 20...